Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Drop as European Authorities Updated About Issues in Belviq - CLSN, DNDN, PATH

Pompano Beach, FL -- (SBWIRE) -- 01/22/2013 -- No Limit Stocks - NOLIMITSTOCKS.com covers all the latest on up and coming stocks in the market. No limit Stocks team contain experts that study and analyzes the stock market and help individuals break through the limits and make them better & more successful investors.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stated that European officials have notified the biopharmaceutical firm of problems with its weight-loss drug Belviq.

The problems must be addressed in writing and orally ahead of regulators will think about the drug’s authorization in the European Union.

What ARNA’s Charts Are Signaling for Traders? Find Out Here

A last decision on EU authorization is still likely in the first half of 2013. Shares dropped 8.4% to $8.95 in the early trade of US stock market.

Arena Pharmaceuticals, Inc. is among corporations with shares likely to trade aggressively in Tuesday’s regular session.

So far today, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares lost -6.76% to $9.11 while the stock is changing hands within a range of $8.80 – $9.16. In the past year, the stock has traded between $1.54 and $13.50. Its average daily trading volume is 10.03 million shares.

Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out

Looking at other stocks in the same industry, Celsion Corporation, Dendreon Corporation and NuPathe Inc are in the top volume leaders. Let’s have a quick look on their Market performance.

Celsion Corporation (NASDAQ:CLSN) shares are up +7.00% to $7.49 while the stock is trading within the range of $7.22 – $7.90 in the current trading session. In the last 12 months, shares have floated between $1.63 and $9.44. This stock, on average, has trading volume of 2.03 million shares.

What was the Moving Force behind CLSN On Bullish Run? Read This Research Report

In this session so far, Dendreon Corporation (NASDAQ:DNDN) shares moved down -0.79% reaching $6.26. The stock is trading in a range of $6.18 – $6.46. In the last year the stock has moved within a range of $3.69 – $17.04. The Company’s average daily trading volume is 7.46 million shares.

Has DNDN Found The Bottom And Ready To Gain Momentum? Find Out Here

Another rival company, NuPathe Inc (NASDAQ:PATH), is trending +2.73% higher to $3.39. The stock price is hovering in range of $3.34 to $3.50. In the previous 52 weeks, shares price ranged between $1.87 and $5.10. Their average daily trading volume is 619,735 shares.

Will PATH Continue To Move Higher? Find Out Here

About No Limit Stocks
NOLIMITSTOCKS.com is made up of a team of professional analyst that possess over 30 years of expert, stock market experience. Our goal is to research thousands of companies and provide investors with the latest insights in the market with stocks that can make explosive profits. We study the hottest companies so you don't have to!

Our newsletter is always free to Join and offers a variety of useful investors tools that will help you break the limits! There will be no regrets!

Disclaimer
The assembled information disseminated by nolimitstocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. nolimitstocks.com does expect that investors will buy and sell securities based on information assembled and presented in nolimitstocks.com. PLEASE always do your own due diligence, and consult your financial advisor.